Travel distance to tertiary sarcoma centres does not influence oncological presentation or outcomes
Contrary to previous studies, our findings suggest that travel distance did not influence disease presentation or survival outcomes in STS patients treated at a centralized sarcoma centre. This challenges previous notions regarding the impact of travel distance on cancer outcomes, and supports the effectiveness of centralized care models, even in geographically vast regions.
Authors
- Jay S. Wunder (ORCID: https://orcid.org/0000-0002-5978-9400)
- Liuzhe Zhang (ORCID: https://orcid.org/0000-0003-0656-2365)
- Peter C. Ferguson (ORCID: https://orcid.org/0000-0003-2630-112X)
- Aaron Gazendam (ORCID: https://orcid.org/0000-0002-2615-4919)
- Anthony M. Griffin (ORCID: https://orcid.org/0000-0003-4462-3974)
- David Clever
- Kim Tsoi (ORCID: https://orcid.org/0000-0002-9811-2187)
Institutions
- University of Toronto (CA)
- Sinai Health System (CA)
Publication Details
- Journal
- The Bone & Joint Journal
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1302/0301-620x.107b3.bjj-2024-0488.r1
- Citations
- 1
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52